Radiomics
PrivateLast Round
Grant
Apr 7, 2023
Total Funding Raised
$9.27M
Company Overview
Radiomics is a biotechnology company providing an AI-powered medical imaging and advanced statistics platform to optimize the development of new oncology treatments for biotech and pharma companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Radiomics Comparables
Compare Radiomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Image Analysis Group | 85% | |
| Onc.ai | 78% | |
| Quibim | 77% | |
Radiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 7, 2023 | ||||
| Series A | Nov 17, 2021 | ||||
| Seed | Feb 20, 2018 |
Radiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public service of Wallonia | Grant |
| Noshaq | Seed, Series A |
| Epimede | Series A |
| LeanSquare | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 36% MoM, reaching 1.2K.
- May 3, 2025
Monthly visitors grew 148% MoM.
Radiomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Radiomics's valuation, stock price, and market status.